| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/08/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 4.4% stake in ANNEXON, INC. |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
4
| Van Meter Stephen (VP, Chief Compliance Officer) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Sold 74 shares
@ $33.1682, valued at
$2.5k
|
|
| 07/27/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 07/07/2023 |
SC 13G/A
| BlackRock Inc. reports a 8.8% stake in FEDERATED HERMES, INC |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| Uhlman Paul A (Vice President) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Sold 1,004 shares
@ $38.543, valued at
$38.7k
|
|
| 06/09/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 3.9% stake in MALLINCKRODT PLC |
| 06/09/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 16.7% stake in FUSION PHARMACEUTICALS, INC. |
| 05/30/2023 |
4
| DONAHUE J CHRISTOPHER (Chairman, President & CEO) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Sold 52,963 shares
@ $35.9843, valued at
$1.9M
|
|
| 05/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
4
| Uhlman Paul A (Vice President) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Sold 995 shares
@ $35.387, valued at
$35.2k
|
|
| 05/26/2023 |
4
| Germain Peter J (EVP, CLO & Sec.) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Sold 2,380 shares
@ $35.471, valued at
$84.4k
|
|
| 05/26/2023 |
4
| DONAHUE J CHRISTOPHER (Chairman, President & CEO) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Sold 25,000 shares
@ $35.3467, valued at
$883.7k
Sold 75,000 shares
@ $35.3759, valued at
$2.7M
|
|
| 05/19/2023 |
4
| DONAHUE THOMAS R (VP, CFO & Treasurer) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Gifted 15,000 shares
@ $0 |
|
| 05/15/2023 |
4
| DONAHUE J CHRISTOPHER (Chairman, President & CEO) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Sold 30,561 shares
@ $37.4982, valued at
$1.1M
|
|
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 9% stake in SERES THERAPEUTICS, INC. |
| 05/10/2023 |
SC 13G/A
| FEDERATED HERMES, INC. reports a 19.9% stake in REGULUS THERAPEUTICS, INC. |
| 05/08/2023 |
4
| FISHER JOHN B (Vice President) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Gifted 37,500 shares
@ $0 |
|
| 05/08/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/02/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/28/2023 |
4
| FARRELL MICHAEL J (Director) has filed a Form 4 on FEDERATED HERMES, INC.|
Txns:
| Granted 2,400 shares
@ $0 |
|
| 04/27/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|